Transdiagnostic use of 3,4-methylenedioxymethamphetamine-assisted therapy to treat obsessive-compulsive disorder.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40001303.
- Also identified by DOI 10.1192/bjp.2024.277.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article explores the potential of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy to enhance exposure and response prevention in obsessive-compulsive disorder treatment. We discuss the mechanisms of MDMA, including fear extinction, psychological flexibility, and empathogenic effects that may improve adherence and efficacy, as well as highlighting important safety considerations for further research.
Medical subject headings
- Obsessive-Compulsive Disorder
- N-Methyl-3,4-methylenedioxyamphetamine
- Hallucinogens
- Implosive Therapy